• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于儿童癌症治疗目的的传统医学和补充医学:一项系统评价。

Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review.

作者信息

Diorio Caroline, Salena Kristen, Ladas Elena J, Lam Catherine G, Afungcwhi Glenn M, Njuguna Festus, Marjerrison Stacey

机构信息

McMaster Children's Hospital, Hamilton, Ontario, Canada.

Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26501. Epub 2017 Feb 28.

DOI:10.1002/pbc.26501
PMID:28244653
Abstract

Traditional and complementary medicine (T&CM) strategies are widely utilized in pediatric oncology, with many families reporting T&CM use with the intention to cure cancer. Study of T&CM agents presents many challenges, as a heterogeneous group of agents and techniques are used for a variety of different purpose in many different oncologic conditions. We present a systematic review of the literature examining published reports in which T&CM agents are used with an intention of cure. Twenty-two reports were identified, with most reports being of poor quality. Novel paradigms are likely needed to further investigate T&CM agents.

摘要

传统医学与补充医学(T&CM)策略在儿科肿瘤学中被广泛应用,许多家庭报告使用T&CM旨在治愈癌症。对T&CM药物的研究面临诸多挑战,因为在许多不同的肿瘤疾病中,一组异质性的药物和技术被用于各种不同目的。我们对文献进行了系统回顾,审视了那些使用T&CM药物旨在治愈癌症的已发表报告。共确定了22份报告,大多数报告质量较差。可能需要新的范式来进一步研究T&CM药物。

相似文献

1
Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review.用于儿童癌症治疗目的的传统医学和补充医学:一项系统评价。
Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26501. Epub 2017 Feb 28.
2
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
4
Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review.全球传统医学和补充医学在儿童癌症中的应用:一项系统评价。
J Glob Oncol. 2017 Dec;3(6):791-800. doi: 10.1200/JGO.2016.005587. Epub 2016 Nov 9.
5
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Examining patterns of traditional Chinese medicine use in pediatric oncology: A systematic review, meta-analysis and data-mining study.考察中医在儿科肿瘤学中的应用模式:系统评价、荟萃分析和数据挖掘研究。
J Integr Med. 2022 Sep;20(5):402-415. doi: 10.1016/j.joim.2022.06.003. Epub 2022 Jun 10.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement.儿科肿瘤学营养需求的管理:一份共识声明。
Cancers (Basel). 2022 Jul 11;14(14):3378. doi: 10.3390/cancers14143378.
2
Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.儿科肿瘤患者在治疗前后使用补充和替代医学。
BMC Complement Med Ther. 2021 Mar 18;21(1):96. doi: 10.1186/s12906-021-03271-9.
3
'A world of competing sorrows': A mixed methods analysis of media reports of children with cancer abandoning conventional treatment.
“充满痛苦的世界”:对媒体报道的癌症儿童放弃常规治疗的混合方法分析。
PLoS One. 2018 Dec 21;13(12):e0209738. doi: 10.1371/journal.pone.0209738. eCollection 2018.
4
The Ethics of Using Complementary Medicine in Pediatric Oncology Trials: Reconciling Challenges.儿科肿瘤试验中使用补充医学的伦理问题:应对挑战
J Law Med Ethics. 2018 Mar;46(1):64-71. doi: 10.1177/1073110518766018. Epub 2018 Mar 27.
5
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.植物次生代谢产物作为抗癌剂:临床试验和治疗应用的成功。
Int J Mol Sci. 2018 Jan 16;19(1):263. doi: 10.3390/ijms19010263.